Christopher W. Fulton

Array ( [id] => 8708534 [patent_doc_number] => 20130065823 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-14 [patent_title] => 'Supplement for Strengthening the Muscles of a Human' [patent_app_type] => utility [patent_app_number] => 13/232032 [patent_app_country] => US [patent_app_date] => 2011-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1833 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13232032 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10090183 [patent_doc_number] => 09126997 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2015-09-08 [patent_title] => 'Synergistic effect of glucocorticoid receptor agonists in combination with proteosome inhibitors for treating leukemia and myeloma' [patent_app_type] => utility [patent_app_number] => 13/226865 [patent_app_country] => US [patent_app_date] => 2011-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5293 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13226865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10155765 [patent_doc_number] => 09187523 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-17 [patent_title] => 'Substrate peptide sequences for plague plasminogen activator and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/199407 [patent_app_country] => US [patent_app_date] => 2011-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 27 [patent_no_of_words] => 10266 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13199407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8566095 [patent_doc_number] => 20120328666 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-27 [patent_title] => 'ORAL DELIVERY OF PEPTIDE PHARMACEUTICAL COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/219132 [patent_app_country] => US [patent_app_date] => 2011-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10509 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13219132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7784675 [patent_doc_number] => 20120046231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'COMPOSITION AND PROCESS FOR SYNTHESIZING POLYMERIZED HUMAN SERUM ALBUMIN FOR APPLICATIONS IN TRANSFUSION MEDICINE' [patent_app_type] => utility [patent_app_number] => 13/215473 [patent_app_country] => US [patent_app_date] => 2011-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4977 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20120046231.pdf [firstpage_image] =>[orig_patent_app_number] => 13215473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7651815 [patent_doc_number] => 20110301084 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'Protracted Exendin-4 Compounds' [patent_app_type] => utility [patent_app_number] => 13/212439 [patent_app_country] => US [patent_app_date] => 2011-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10431 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0301/20110301084.pdf [firstpage_image] =>[orig_patent_app_number] => 13212439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8555191 [patent_doc_number] => 08329662 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-11 [patent_title] => 'Prodrug of an ICE inhibitor' [patent_app_type] => utility [patent_app_number] => 13/210712 [patent_app_country] => US [patent_app_date] => 2011-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8036 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13210712 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7568208 [patent_doc_number] => 20110288271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'AGENT DERIVED FROM TORTOISE SPLEEN STIMULATING MAMMALIAN HEMOPOIESIS' [patent_app_type] => utility [patent_app_number] => 13/195093 [patent_app_country] => US [patent_app_date] => 2011-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 10131 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20110288271.pdf [firstpage_image] =>[orig_patent_app_number] => 13195093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8483057 [patent_doc_number] => 20120282464 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-08 [patent_title] => 'Spherical Protein Particles and Methods of Making and Using Them' [patent_app_type] => utility [patent_app_number] => 13/192345 [patent_app_country] => US [patent_app_date] => 2011-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 30776 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13192345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7501500 [patent_doc_number] => 20110263506 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'PEPTIDES HAVING AN ACE INHIBITING EFFECT' [patent_app_type] => utility [patent_app_number] => 13/179078 [patent_app_country] => US [patent_app_date] => 2011-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7628 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263506.pdf [firstpage_image] =>[orig_patent_app_number] => 13179078 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8214255 [patent_doc_number] => 08193156 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2012-06-05 [patent_title] => 'Dipeptides incorporating selenoamino acids with enhanced bioavailability—synthesis, pharmaceutical and cosmeceutical applications thereof' [patent_app_type] => utility [patent_app_number] => 13/175016 [patent_app_country] => US [patent_app_date] => 2011-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8842 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/193/08193156.pdf [firstpage_image] =>[orig_patent_app_number] => 13175016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8265831 [patent_doc_number] => 20120165258 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'Compositions and Methods for Treatment of Thrombosis and for Prolonging Survival of Stored Platelets' [patent_app_type] => utility [patent_app_number] => 13/168048 [patent_app_country] => US [patent_app_date] => 2011-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13163 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13168048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7754524 [patent_doc_number] => 20120027720 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'PEPTIDE CONJUGATES' [patent_app_type] => utility [patent_app_number] => 13/168734 [patent_app_country] => US [patent_app_date] => 2011-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 16524 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20120027720.pdf [firstpage_image] =>[orig_patent_app_number] => 13168734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487782 [patent_doc_number] => 20110236547 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'METHODS FOR SEPARATING PROTEINS FROM CONNECTIVE TISSUE' [patent_app_type] => utility [patent_app_number] => 13/151846 [patent_app_country] => US [patent_app_date] => 2011-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11024 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20110236547.pdf [firstpage_image] =>[orig_patent_app_number] => 13151846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9524304 [patent_doc_number] => 08748570 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-10 [patent_title] => 'Insulin analogues' [patent_app_type] => utility [patent_app_number] => 13/502085 [patent_app_country] => US [patent_app_date] => 2011-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 82121 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13502085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7502200 [patent_doc_number] => 20110263817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'METAL-BINDING COMPOUNDS AND USES THEREFOR' [patent_app_type] => utility [patent_app_number] => 13/110550 [patent_app_country] => US [patent_app_date] => 2011-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 31734 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263817.pdf [firstpage_image] =>[orig_patent_app_number] => 13110550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8489123 [patent_doc_number] => 20120288530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-15 [patent_title] => 'TISSUE SEALANTS FROM PLASMA DERIVED PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/107375 [patent_app_country] => US [patent_app_date] => 2011-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9327 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13107375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7587390 [patent_doc_number] => 20110281900 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'Crystalline Pharmaceutical' [patent_app_type] => utility [patent_app_number] => 13/107780 [patent_app_country] => US [patent_app_date] => 2011-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 12115 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20110281900.pdf [firstpage_image] =>[orig_patent_app_number] => 13107780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9749479 [patent_doc_number] => 08840950 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-23 [patent_title] => 'Compositions of nutrition supplementation for nutritional deficiencies and method of use therefore' [patent_app_type] => utility [patent_app_number] => 13/105383 [patent_app_country] => US [patent_app_date] => 2011-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 19 [patent_no_of_words] => 5314 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13105383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5936042 [patent_doc_number] => 20110212139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'HIGH-DENSITY LIPOPROTEIN COATED MEDICAL DEVICES' [patent_app_type] => utility [patent_app_number] => 13/102791 [patent_app_country] => US [patent_app_date] => 2011-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7803 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212139.pdf [firstpage_image] =>[orig_patent_app_number] => 13102791 [rel_patent_id] =>[rel_patent_doc_number] =>)